Risk of Recurrent Coronary Events in Patients With Familial Hypercholesterolemia; A 10-Years Prospective Study

Risk of Recurrent Coronary Events in Patients With Familial Hypercholesterolemia; A 10-Years Prospective Study

Background and Aim: Real world evidence on long term treatment of patients with familial hypercholesterolemia (FH) is important. We studied the effects of intensive lipid lowering medication (LLM) and optimized lifestyle in the study TTTFH–Treat To Target FH.Materials and Methods: Adults with a firs...

Full description

Bibliographic Details
Main Authors: Kjell-Erik Arnesen, Ann Vinh Phung, Karoline Randsborg, Irene Mork, Marlene Thorvall, Gisle Langslet, Arne Svilaas, Cecilie Wium, Leiv Ose, Kjetil Retterstøl
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Pharmacology
Subjects:
familial hypercholesterolemia
ASCVD
side effect
TTTFH
statin
PCSK9-inhibitor
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2020.560958/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2020.560958/full

Similar Items